The product that is at the center of the dispute is a self-administered urinalysis test kit with yearly sales in Taiwan of more than NT $ 10 billion that can be used by women to see if they are pregnant or by schools and the military to test for drugs. It can even check for osteoporosis and coronary thrombosis.
普司通案的爭議產品，是在台灣市場年營業額可達百億元的自助式檢驗試劑，不管是婦女在家裡做驗孕、或是軍中和學校大規模的毒品驗尿測試，甚至骨質疏鬆、心肌梗塞等疾病的高危險群，都可以在家裡自行檢測。